About 14 results found for searched term "CB1 agonist 1" (0.125 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M21427 | CB1 agonist 1 | Cannabinoid |
| CB1 agonist 1 is an agonist of CB1. The pIC50 value of CB1 agonist 1 affinity with CB1 receptor was 5.7. CB1 agonist 1 can be used in the study of brain disorders. | ||
| M2051 | CP 945598 hydrochloride | Cannabinoid |
| Otenabant HCl; Otenabant hydrochloride | ||
| CP 945598 hydrochloride is a selective and high affinity CB1 antagonist (Ki values are 0.7 and 0.12 nM in binding and functional assays respectively). | ||
| M5290 | (±)-SLV-319 | Cannabinoid |
| (±)-Ibipinibant; BMS-646256 | ||
| (±)-SLV319 (Ibipinabant) is a potent and selective CB1 receptor antagonist (Ki = 7.8 nM). Exhibits 1000-fold selectivity for CB1 over CB2 receptors. Inhibits CP 55,940-induced hypotension and WIN 55,212-2-induced hypothermia in vivo. | ||
| M8919 | BAY 59-3074 | Cannabinoid |
| BAY-59-3074 is a novel cannabinoid CB1/CB2 receptor partial agonist with Ki values of 48.3 and 45.5 nM at human CB1 and CB2 receptors, respectively. | ||
| M8280 | PSNCBAM-1 | Others |
| PSNCBAM-1 is an allosteric, non-competitive antagonist of CB-1. | ||
| M9652 | CB1-IN-1 | Cannabinoid |
| DBPR211; BPRCB1184 | ||
| CB1-IN-1 is a novel potent restricted CB1R antagonist with Ki of 0.3 nM and 21 nM for CB1R and CB2R, respectively. | ||
| M9691 | JD-5037 | Cannabinoid |
| JD5037; CRB-4001 | ||
| JD-5037 is a cannabinoid-1 receptor blocker (CB1R antagonist) with IC50 of 1.5 nM. | ||
| M10789 | AZD1940 | Cannabinoid |
| AZD1940 is an orally active, high-affinity CB1/CB2 receptor agonist for CB1R and CB2R pKi the values are 7.93 and 9.06, respectively, and can be used in studies that relieve pain. | ||
| M10891 | Taranabant | Others |
| MK-0364 | ||
| Taranabant is a potent and selective cannabinoid 1 (CB1) receptor reverse agonist that inhibits binding and the functional activity of multiple agonists, acting on human CB1R,Ki 0.13 nM. | ||
| M29263 | BAY 38-7271 | Cannabinoid |
| BAY 38-7271 is selective and highly potent and cannabinoid CB1/CB2 receptor agonist, with Kis of 1.85 nM and 5.96 nM for recombinant human CB1 receptor and CB2 receptor, respectively. BAY 38-7271 has strong neuroprotective properties. | ||
| M29983 | Drinabant | Cannabinoid |
| AVE1625 | ||
| Drinabant (AVE1625) is an orally active CB1 receptor antagonist. Drinabant (AVE1625) inhibits the agonist-stimulated calcium signal with IC50 values of 25 nM and 10 nM for the hCB1-R and rCB1-R, respectively, and is ineffective for the hCB2-R. | ||
| M30911 | CB2 receptor agonist 3 | Cannabinoid |
| GP2a | ||
| CB2 receptor agonist 3 is a robust and selective CB2 cannabinoid agonist with Kis of 7.6 and 900 nM for CB2 and CB1, respectively. CB2 receptor agonist 3 significantly increases P-ERK 1/2 expression in HL-60 cells. | ||
| M54196 | RVD-Hpα TFA | Cannabinoid |
| RVD-Hpα TFA is the N-terminally extended form of human hemopressin that acts as a selective CB1 receptor agonist. RVD-Hpα TFA increases intracellular Ca2+ levels in cells expressing CB1 receptors in vitro. RVD-Hpα TFA also high affinity CB2 positive allosteric modulator (Ki=50 nM). | ||
| M56148 | TC-C 14G | Cannabinoid |
| TC-C 14G (Compd 14g) is a Cannabinoid-1 Receptor (CB1R) inverse agonist, with a Ki of 4 nM and EC50 of 11 nM for HCB1R, respectively. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
